Latest Sustainability News

Monadelphous Group Limited reported a robust FY25 with $2.27 billion revenue and $158 million net profit, underpinned by strong contract wins and growth in energy and resources sectors.

Challenger Limited reported a robust FY25 with a 9% rise in normalised profit and a strategic push into digital transformation and retirement income solutions.

Challenger Limited celebrates four decades with a robust 9% rise in net profit and a strategic digital transformation, positioning itself at the forefront of Australia’s retirement income market.

Monadelphous Group Limited has reported a robust 35% increase in net profit for the 2025 financial year, alongside a 7% revenue rise, prompting a notable dividend hike.

HUB24 Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending June 2025, signaling steady shareholder returns ahead of the payment date in October.

Sims Limited reported a 4.1% increase in sales revenue to A$7.494 billion for FY25, alongside a 48.1% jump in underlying EBITDA to A$430 million. Despite a statutory net loss, the company declared a fully franked final dividend of 13 cents per share, reflecting confidence amid market challenges and portfolio reshaping.

HUB24 Limited reported robust FY25 results with revenue climbing 24% to $406.6 million and underlying net profit after tax soaring 44%. The company’s platform funds under administration grew 34%, underpinning a 47% increase in fully franked dividends.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

CSL Limited reported robust FY25 results alongside a sweeping strategic overhaul, including a major cost-saving program and plans to spin off its vaccine unit CSL Seqirus as a standalone ASX-listed company.

CSL Limited posted a 14% rise in net profit for FY2025, underpinned by strong immunoglobulin sales and new product launches, while announcing plans to demerge its vaccines business, CSL Seqirus, to sharpen strategic focus.

Judo Capital Holdings delivered a robust FY25 with strong loan and deposit growth, improved profitability, and a strategic technology upgrade, setting the stage for ambitious FY26 targets.

HMC Capital reported a robust FY25 with a 51% rise in operating EPS and a 47% jump in assets under management to $18.7 billion, driven by expansion across multiple funds management divisions.